MagicMed Targets Massive Market with Pharmaceutical Derivatives Program
December 23, 2020
Ryan Allway December 23rd, 2020 App, Exclusive, Psychedelics, Top Story The psychedelics market is hard to calculate because of the undiscovered therapeutic potential of psychedelic molecules. The scientific community has shown that psychedelics could treat multiple multibillion-dollar markets in the brain and mental health space. MagicMed Industries positions itself... Read more
Psychedelics Production Challenges & Solutions
December 21, 2020
Ryan Allway December 21st, 2020 App, Exclusive, Psychedelics, Top News Psilocybin and other tryptamine-based compounds could become blockbuster therapeutics for the treatment of depression, post-traumatic stress disorder and other difficult to treat psychiatric conditions. While many clinical trials are underway, researchers are turning their attention toward the problem of... Read more
Innovation zahlt sich aus bei Psychedelika
December 18, 2020
Es besteht ein erhebliches Interesse am psychedelischen Bereich und an den vielversprechenden psychedelischen Molekülen für die Behandlung von psychischen Erkrankungen. Geisteskrankheiten sind eine allgegenwärtige menschliche Erfahrung und eine bisher nur unzureichend behandelte medizinische Notwendigkeit. Psychedelika bieten eine Alternative zu unwirksamen Behandlungen, da sie über andere Wirkmechanismen funktionieren. Psychedelische Arzneimittel... Read more
Ryan Allway December 18th, 2020 App, Exclusive, News, Top News Charlotte’s Web Holdings Inc. (TSX: CWEB) bought Abacus Health Products Inc. in a stock transaction worth about $100 million last June. With competition on the rise in the CBD industry, Abacus provided Charlotte’s Web with a portfolio of over-the-counter... Read more
Innovation Pays Off in Psychedelics
December 18, 2020
Ryan Allway December 18th, 2020 App, Exclusive, Psychedelics, Top Story There has been significant interest in the psychedelic space and of the promise psychedelic molecules show in treating mental health conditions. Mental illness is a ubiquitous human experience and an insufficiently addressed medical necessity. Psychedelics offer an alternative to... Read more
Why Focus on Cannabis & Mushroom Extracts?
CBD November 25, 2020
Ryan Allway November 25th, 2020 App, Exclusive, News, Top Story Cannabis extracts are poised to become a $28.5 billion market by 2027, according to Grand View Market Research, representing a 16.6% compound annual growth rate. At the same time, the functional mushroom market is forecast to reach $34.3 billion... Read more
Edible Manufacturing a Key to Cannabis Market Growth
November 19, 2020
Robin Lefferts November 19th, 2020 Exclusive, Top News It’s been about a year since Canada, following up on the national legalization of adult-use cannabis, allowed ingestible (edible and drinkable) products on the market. It took a few months for some products to hit the shelves and find traction, but... Read more
How to Invest in the Rise of Cannabis-Infused Beverages
November 18, 2020
Ryan Allway November 18th, 2020 App, Exclusive, News, Top Story The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry... Read more
Ryan Allway November 6th, 2020 Exclusive, German, Psychedelics Die meisten Pharma- und Biotech-Investoren sind mit langen Kommerzialisierungsfristen vertraut, aber es gibt einige Möglichkeiten, diese zu verkürzen. Beispielsweise bietet die Food and Drug Administration für bestimmte Therapien, die auf lebensbedrohliche Erkrankungen abzielen, Bezeichnungen wie Fast Track, Durchbruchstherapie, beschleunigte Zulassung und... Read more
Ryan Allway November 6th, 2020 App, Exclusive, News, Top Story Cannabidiol, better known as CBD, has become one of the fastest growing segments of the health and wellness industry. According to BDS Analytics and ArcView, CBD sales will grow at a 49% compound annual growth rate to exceed $20... Read more
